Levodopa‐induced dyskinesia in Parkinson disease: current and evolving concepts

AJ Espay, F Morgante, A Merola, A Fasano… - Annals of …, 2018 - Wiley Online Library
Levodopa‐induced dyskinesia is a common complication in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …
被引用次数：293 相关文章
[PDF] core.ac.uk

[PDF][PDF] REVIEW–Manuscript# ANA-18-0800 Levodopa-induced dyskinesia in Parkinson disease: Current and Evolving Concepts

AJ Espay, F Morgante, A Merola, A Fasano, L Marsili… - core.ac.uk
Levodopa-induced dyskinesia are common complications in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …

[引用][C] Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts

AJ Espay, F Morgante, A Merola, A Fasano… - ANNALS OF …, 2018 - research.unipg.it
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English …
[PDF] researchgate.net

[PDF][PDF] Levodopa-Induced Dyskinesia in Parkinson Disease: Current and Evolving Concepts

AJ Espay, F Morgante, A Merola, A Fasano, L Marsili… - 2018 - researchgate.net
Levodopa-induced dyskinesia is a common complication in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …

Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.

AJ Espay, F Morgante, A Merola, A Fasano… - Annals of …, 2018 - europepmc.org
Levodopa-induced dyskinesia is a common complication in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …
[PDF] academia.edu

[PDF][PDF] REVIEW–Manuscript# ANA-18-0800 Levodopa-induced dyskinesia in Parkinson disease: Current and Evolving Concepts

AJ Espay, F Morgante, A Merola, A Fasano, L Marsili… - academia.edu
Levodopa-induced dyskinesia are common complications in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …

Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts

AJ Espay, F Morgante, A Merola… - Annals of …, 2018 - ohiostate.elsevierpure.com
Levodopa-induced dyskinesia is a common complication in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …

Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

AJ Espay, F Morgante, A Merola, A Fasano… - Annals of …, 2018 - cir.nii.ac.jp
抄録< jats: p> Levodopa‐induced dyskinesia is a common complication in Parkinson
disease. Pathogenic mechanisms include phasic stimulation of dopamine receptors …

Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts

A Espay, F Morgante, A Merola, A Fasano… - ANNALS OF …, 2018 - iris.uniroma5.it
Levodopa-induced dyskinesia is a common complication in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …

Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts

AJ Espay, F Morgante, A Merola, A Fasano… - ANNALS OF …, 2018 - publicatt.unicatt.it
Levodopa-induced dyskinesia is a common complication in Parkinson disease. Pathogenic
mechanisms include phasic stimulation of dopamine receptors, nonphysiological levodopa …